Skip to search formSkip to main contentSkip to account menu

lesopitron

Known as: 2-(4-(4-(4-chloro-1-pyrazolyl)butyl)-1-piperazinyl)pyrimidine, 2-(4-(4-(4-Chloropyrazol-1-yl)butyl)-1-piperazinyl)pyrimidine, Pyrimidine, 2-(4-(4-(4-chloro-1H-pyrazol-1-yl)butyl)-1-piperazinyl)-, dihydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Lesopitron acts as a ligand for central serotonin 5-HT1A receptors. Ki obtained from [3H]8-OH-DPAT competition studies was 104.8… 
2000
2000
OBJECTIVE: To compare the relative efficacy and safety of lesopitron 40–80 mg/d versus lorazepam 2–4 mg/d and placebo in a… 
1999
1999
We investigated the effects of two 5-HT1A receptor agonists, buspirone and lesopitron, upon pupil size in human volunteers at an… 
1997
1997
Disposition of [14C]-lesopitron was investigated in male rats and dogs after single and repeated oral administration… 
1996
1996
The novel 5-HT1A receptor antagonist WAY 100635 [(N-(2-(-4(2-metoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyc lohexane… 
1994
1994
1 The involvement of presynaptic 5‐hydroxytryptamine1A (5‐HT1A) autoreceptors in the anxiolytic‐like properties of lesopitron (E… 
1993
1993
SummaryThe potential 5-HT1A antagonist properties of the ß-antagonist tertatolol were assessed using biochemical and…